Nasonal 0,5 Mg/Ml (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nasonal 0,5 Mg/Ml, is an alpha-adrenergic agonist presented as a 0.5 mg/mL nasal solution for nasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis in adults and children.

GNH USA supplies Nasonal 0,5 Mg/Ml as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline Hydrochloride acts on nasal mucosal blood vessels to reduce swelling and improve airflow in several common upper‑respiratory conditions.

- Common cold nasal congestion: reduces swelling of nasal mucosa to improve breathing. - Sinusitis‑related congestion: alleviates blockage and pressure in the nasal passages. - Allergic rhinitis: decreases nasal swelling caused by allergic inflammation.

Nasonal may cause a range of local and systemic reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal mucosa. - Sneezing or mild headache. - Altered taste or mild throat discomfort.

Serious or Rare Side Effects: - Rebound congestion (rhinitis medicamentosa) after prolonged use. - Severe hypertension or cardiovascular strain. - Nasal ulceration or tissue necrosis. - Allergic reactions including rash, swelling, or anaphylaxis. - Ocular irritation if the spray contacts the eyes. - Arrhythmias in susceptible individuals.

Before using Nasonal, consider the following safety measures.

- Age limitation: avoid prolonged use in children under 6 years unless directed by a healthcare professional. - Duration of use: limit treatment to 3‑5 days to prevent rebound congestion. - Cardiovascular conditions: use with caution in patients with hypertension or heart disease. - Pregnancy and lactation: consult a healthcare professional before use. - Drug interactions: discuss all nasal or systemic decongestants with the prescriber. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nasonal can interact with other sympathomimetic agents and certain cardiovascular drugs.

Major Interactions (Avoid): - Oral or topical sympathomimetic decongestants: additive vasoconstriction may raise blood pressure. - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Tricyclic antidepressants: may increase cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt the cardiovascular response to the nasal spray. - Antihypertensive agents: monitor blood pressure for potential reduction. - Nasal corticosteroids: generally safe but monitor for local irritation.